Table 6.
Adverse Effects | Intervention Group | Control Group | |||
---|---|---|---|---|---|
Frequency | Proportion (%) | Frequency | Proportion (%) | ||
Behavioral Toxicity | Excitement or arousal | 1 | 0.15 | 5 | 0.73 |
Decreased activity | 2 | 0.29 | 4 | 0.58 | |
Insomnia | 21 | 3.07 | 38 | 5.55 | |
Sleepiness | 9 | 1.31 | 21 | 3.07 | |
Nervous System | Tremor | 3 | 0.44 | 11 | 1.61 |
Restlessness | 0 | 0.00 | 3 | 0.44 | |
Dizziness and headache | 38 | 5.55 | 55 | 8.03 | |
Dry mouth | 34 | 4.96 | 49 | 7.15 | |
Vegetative Nervous System | Blurred vision | 4 | 0.58 | 11 | 1.61 |
Constipation | 23 | 3.36 | 39 | 5.69 | |
Sweating | 1 | 0.15 | 7 | 1.02 | |
Nausea and vomiting | 29 | 4.23 | 52 | 7.59 | |
Diarrhea | 9 | 1.31 | 12 | 1.75 | |
Cardiovascular System | Lower blood pressure | 4 | 0.58 | 9 | 1.31 |
Heartburn and palpitations | 6 | 0.88 | 22 | 3.21 | |
High blood pressure | 2 | 0.29 | 1 | 0.15 | |
Electrocardiogram abnormalities | 4 | 0.58 | 5 | 0.73 | |
Heart attack | 1 | 0.15 | 0 | 0.00 | |
Other | Itchy skin or rash | 3 | 0.44 | 10 | 1.46 |
Weight gain | 5 | 0.73 | 5 | 0.73 | |
Loss of appetite or anorexia | 22 | 3.21 | 37 | 5.40 | |
Abnormal liver function | 2 | 0.29 | 3 | 0.44 | |
Difficulty in urination | 5 | 0.73 | 7 | 1.02 | |
Anxiety | 2 | 0.29 | 5 | 0.73 | |
Fatigue | 6 | 0.88 | 8 | 1.17 | |
Sexual dysfunction | 2 | 0.29 | 8 | 1.17 | |
Chest tightness | 1 | 0.15 | 2 | 0.29 | |
Menstrual disorders | 1 | 0.15 | 1 | 0.15 | |
Mild burns | 2 | 0.29 | 0 | 0.00 | |
Acupuncture pain | 3 | 0.44 | 0 | 0.00 | |
Subcutaneous hematoma | 3 | 0.44 | 0 | 0.00 | |
Acupuncture dizziness | 6 | 0.88 | 0 | 0.00 | |
Hospitalization after external stimulation | 1 | 0.15 | 0 | 0.00 |